adamantane has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avramis, IA; Avramis, VI; Christodoulopoulos, G; Gonzalez-Gomez, I; Laug, WE; McNamara, G; Sausville, EA; Suzuki, A | 1 |
1 other study(ies) available for adamantane and Leukemia, Lymphocytic, T Cell
Article | Year |
---|---|
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Topics: Adamantane; Animals; Blotting, Western; Brain Neoplasms; Caspase 3; Caspases; DNA, Neoplasm; Drug Resistance, Neoplasm; Endothelial Growth Factors; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Female; Fusion Proteins, bcr-abl; Glioblastoma; Humans; Hydroquinones; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Leukemia, T-Cell; Lymphokines; Mice; Mice, Nude; Myosin Heavy Chains; Neoplasm Transplantation; Nonmuscle Myosin Type IIB; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2002 |